| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f995d39a17ee75b2279be269d711e8b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2001-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7219397bed22a19dcceb760cdc4a39d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff64afc9f494891dde498a8422689de |
| publicationDate |
2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2376468-A |
| titleOfInvention |
Human serine/threonine/tyrosine protein kinase |
| abstract |
Nucleic acid sequences (SEQ ID NO: 1 and 2) encoding a human serine/threonine/tyrosine protein kinase (STTK) of SEQ ID NO: 3 are claimed. Also claimed are vectors and host cells that express STTK, protein fragments and fusion proteins of STTK and antibodies thereto. The invention also claims transgenic cells and non-human organisms comprising STTK. Pharmaceutical compositions comprising the STTK polynucleotide, polypeptide or antibody are also claimed, as are diagnostic methods and assays for antagonists or agonists of STTK activity. Possible roles for STTK in diseases, including Alzheimer's and hemochromatosis are disclosed. |
| priorityDate |
2001-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |